BlueOcean

UpcomingFund
Investment

First Tokenized Medtech VC Fund

Sale Information

-

Start at:
TBA (To be announced)
End at:
TBA (To be announced)
Price:
-
Whitelist / KYC:
KYC & Whitelist
Buy with:
BTC, ETH, Fiat, Other
Restricted areas:
China, Iran, North Korea

General

Token:
BOV
Total supply:
-
Hard Cap:
33,000,000USD
Soft Cap:
3,200,000USD
Platform:
Ethereum
Token Owner Rights:
TBA (To be announced)
Country of incorporation:
Singapore
STO Location:
United Kingdom
Product:
None
2008

Launch of BlueOcean Ventures I

2015

aunch of the second fund, BlueOcean Ventures II

2016

BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA

2017

BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)

MAY 2018

Set up of Special STO Investment Vehicle in Singapore

JULY 2018

BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO

DECEMBER 2018

End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II

BEGINNING OF 2019

BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups

2020/2021

BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company

2025

BlueOcean Ventures II is closed, all remaining assets are distributed to the investors

Emmanuel de Watteville
General Partner and Co-Founder
Thomas Zehnder
General Partner
Antonio Gambardella
Advisor
Jean-Etienne Durand
Head of Operations
Lug Giroud
Head of Marketing
Christophe Saam
Swiss & European Patent Attorney
Olivier Crochat
STO Technology Advisor

Similar STOs

Cookies help us deliver our services. By using our services, you agree to our use of cookies.